Acquired In-Process Research and Development and Other Arrangements (Tables)

6 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Collaborative Arrangement Costs

During the three and six months ended June 30, 2022 and 2021, we recognized the following amounts in total, not including amounts recorded to “Acquired in-process research and development expenses,” related to these agreements:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
	(in millions)
Total expenses incurred under the Original CTX001 JDCA and A&R JDCA	$	85.0	$	55.0	$	161.6	$	95.0
Vertex’s share recognized in “Total costs and expenses” in our condensed consolidated statements of operations	50.9		27.5		96.9		47.5